Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
100%
Lung Neoplasms
96%
Survival
93%
Neoplasms
69%
Robotics
69%
Retinoblastoma
65%
Chest Tubes
63%
Video-Assisted Thoracic Surgery
61%
Esophageal Neoplasms
57%
Heart-Assist Devices
50%
Thorax
47%
Air
47%
Lung
43%
Pneumothorax
42%
Neoplasm Metastasis
41%
Hiatal Hernia
40%
Wounds and Injuries
36%
Therapeutics
36%
Thoracotomy
36%
Thoracic Surgery
36%
ethyl pyruvate
36%
Herniorrhaphy
35%
Adenocarcinoma of Lung
35%
Recurrence
35%
fascin
33%
Malignant Pleural Effusion
32%
Ischemia
32%
Hemothorax
31%
Length of Stay
28%
Surgeons
27%
Adenocarcinoma
27%
Esophagogastric Junction
27%
Tomography
27%
Mortality
26%
Cyclin-Dependent Kinases
24%
Reperfusion
24%
Tumor Biomarkers
23%
Drainage
22%
Internship and Residency
22%
Gastrectomy
21%
Esophagus
21%
Pleurodesis
21%
Morbidity
21%
Adenosine Triphosphate
21%
DNA Replication
21%
Drug Therapy
21%
Indwelling Catheters
20%
Positron-Emission Tomography
19%
deoxyguanosine kinase
19%
Carcinoma
18%
Cell Biology
18%
Vacuum
18%
Ventricular Dysfunction
17%
Radiotherapy
17%
Cyclin-Dependent Kinase 4
17%
Cyclin D1
17%
Squamous Cell Neoplasms
16%
Myotomy
16%
Off-Pump Coronary Artery Bypass
16%
Genes
16%
Heller Myotomy
16%
Quality of Life
15%
Myocardial Ischemia
15%
Animals
15%
Respiratory Insufficiency
15%
Splenic Rupture
15%
Databases
15%
fructose-1,6-diphosphate
15%
Equipment and Supplies
15%
Fused Kidney
15%
Mediastinal Cyst
15%
Lymph Node Ratio
15%
Tracheoesophageal Fistula
15%
Incidence
15%
Radiation
15%
Propensity Score
15%
Suction
15%
Abdominal Hernia
14%
Immunoglobulin G4-Related Disease
14%
Reperfusion Injury
14%
Superior Vena Cava Syndrome
14%
ErbB Receptors
14%
Empyema
14%
Skilled Nursing Facilities
14%
Minimally Invasive Surgical Procedures
14%
Survival Analysis
14%
Cell Cycle Checkpoints
14%
Cystic Duct
14%
Histoplasmosis
14%
Cell Cycle
13%
Extracorporeal Membrane Oxygenation
13%
Thoracic Aortic Aneurysm
13%
Costs and Cost Analysis
13%
Burn Units
13%
Congenital Diaphragmatic Hernias
13%
Trauma Centers
13%
Esophagectomy
13%
Licensure
13%
Neoadjuvant Therapy
13%